Skip to main content
. 2017 Jul 13;8(4):366–374. doi: 10.1007/s13340-017-0325-z

Table 2.

Laboratory, anthropometric, and body-composition parameters of the study patients at baseline and after 6 months

Baseline Follow-up p value
HbA1c (%) 9.1 [8.3, 10.4] 7.2 [6.6, 8.2] <0.001
 Men 9.1 [8.3, 10.5] 7.2 [6.7, 8.4] <0.001
 Women 9.2 [8.2, 10.2] 6.9 [6.3, 7.9] <0.001
Body weight (kg) 73.1 ± 13.5 70.3 ± 12.9 <0.001
 Men 74.9 ± 12.3 72.4 ± 12.2 <0.001
 Women 68.6 ± 15.4 65.3 ± 13.5 0.003
BMI (kg/m2) 27.1 ± 4.2 26.0 ± 4.0 <0.001
 Men 26.6 ± 3.6 25.5 ± 3.6 <0.001
 Women 28.6 ± 5.3 27.2 ± 4.6 0.003
VFA (cm2) 113.4 ± 47.0 92.6 ± 40.5 <0.001
 Men 113.2 ± 47.2 91.1 ± 39.9 <0.001
 Women 114.0 ± 47.5 96.4 ± 42.8 0.001
SFA (cm2) 215.5 ± 75.6 190.8 ± 71.7 <0.001
 Men 204.5 ± 70.4 179.2 ± 60.0 <0.001
 Women 242.1 ± 82.9 219.1 ± 89.7 0.037
ASM (kg) 19.24 ± 3.82 19.27 ± 3.93 0.813
 Men 20.64 ± 3.26 20.67 ± 3.41 0.826
 Women 15.84 ± 2.87 15.85 ± 2.89 0.933

Data are presented as the mean ± SD or the median [interquartile range]. p values were obtained using the paired-sample t test or Wilcoxon’s signed-rank test

BMI body mass index, VFA visceral fat area, SFA subcutaneous fat area, ASM appendicular skeletal muscle mass